Multi-messenger observations of a binary neutron star merger

On 2017 August 17 a binary neutron star coalescence candidate (later designated GW170817) with merger time 12:41:04 UTC was observed through gravitational waves by the Advanced LIGO and Advanced Virgo detectors. The Fermi Gamma-ray Burst Monitor independently detected a gamma-ray burst (GRB 170817A) with a time delay of ~1.7 s with respect to the merger time. From the gravitational-wave signal, the source was initially localized to a sky region of 31 deg2 at a luminosity distance of 40+8-8 Mpc and with component masses consistent with neutron stars. The component masses were later measured to be in the range 0.86 to 2.26 Mo. An extensive observing campaign was launched across the electromagnetic spectrum leading to the discovery of a bright optical transient (SSS17a, now with the IAU identification of AT 2017gfo) in NGC 4993 (at ~40 Mpc) less than 11 hours after the merger by the One- Meter, Two Hemisphere (1M2H) team using the 1 m Swope Telescope. The optical transient was independently detected by multiple teams within an hour. Subsequent observations targeted the object and its environment. Early ultraviolet observations revealed a blue transient that faded within 48 hours. Optical and infrared observations showed a redward evolution over ~10 days. Following early non-detections, X-ray and radio emission were discovered at the transient’s position ~9 and ~16 days, respectively, after the merger. Both the X-ray and radio emission likely arise from a physical process that is distinct from the one that generates the UV/optical/near-infrared emission. No ultra-high-energy gamma-rays and no neutrino candidates consistent with the source were found in follow-up searches. These observations support the hypothesis that GW170817 was produced by the merger of two neutron stars in NGC4993 followed by a short gamma-ray burst (GRB 170817A) and a kilonova/macronova powered by the radioactive decay of r-process nuclei synthesized in the ejecta

Micro-leakage at the implant-abutment interface with different tightening torques in vitro

OBJECTIVES: This study evaluated the microleakage at the implant/abutment interface of external hexagon (EH) implants and abutments with different amounts of bacteria and tightening torques. MATERIAL AND METHODS: A bacterial suspension was prepared to inoculate the implants. The first phase of this study used nine EH implants and abutments that were divided into three groups with different amounts of bacterial suspension (n=3): V0.5: 0.5 µL; V1.0: 1.0 µL e V1.5: 1.5 µL, and tightened to the manufacturer's recommended torque. The second phase of this experiment used 27 assemblies that were similar to those used in the first phase. These samples were inoculated with 0.5 µL of bacterial suspension and divided into three groups (n=9). T10: 10 Ncm; T20: 20 Ncm and T32: 32 Ncm. The samples were evaluated according to the turbidity of the broth every 24 hours for 14 days, and the bacteria viability was tested after that period. The statistical evaluation was conducted by Kruskal-Wallis testing (p<.05). RESULTS: During the first phase, groups V1.0 and V1.5 was presented with bacterial contamination in all samples after 24 h. During the second phase, two samples from group T10 and one from T20 presented positive results for bacterial contamination. Different amounts of bacterial solution led to overflow and contamination during the first 24 h of the experiment. The tightening torques did not statistically affect the microleakage in the assemblies. However, the group that was tightened to 32 Ncm torque did not show any bacterial contamination. CONCLUSION: After 14 days of experimentation, the bacteria were proven to remain viable inside the implant internal cavity

Nucleases as a barrier to gene silencing in the cotton boll weevil, Anthonomus grandis.

Made available in DSpace on 2018-01-04T23:23:41Z (GMT). No. of bitstreams: 1 journal.pone.0189600.pdf: 7131320 bytes, checksum: ece3da5d8a008843e58701868100618d (MD5) Previous issue date: 2018-01-04bitstream/item/170309/1/journal.pone.0189600.pd

Mucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment

Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive impairment. Until the beginning of the XXI century, treatment was mainly supportive. Bone marrow transplantation improved the natural course of the disease in some types of MPS, but the morbidity and mortality restricted its use to selected cases. The identification of the genes involved, the new molecular biology tools and the availability of animal models made it possible to develop specific enzyme replacement therapies (ERT) for these diseases. At present, a great number of Brazilian medical centers from all regions of the country have experience with ERT for MPS I, II, and VI, acquired not only through patient treatment but also in clinical trials. Taking the three types of MPS together, over 200 patients have been treated with ERT in our country. This document summarizes the experience of the professionals involved, along with the data available in the international literature, bringing together and harmonizing the information available on the management of these severe and progressive diseases, thus disclosing new prospects for Brazilian patients affected by these conditions

Prevalência e fatores associados à asma em escolares de Montes Claros, MG, Brasil

Resumo Investigou-se a prevalência de asma e fatores relacionados ao seu desenvolvimento em escolares de 6 a 14 anos residentes em área central e periférica da cidade de Montes Claros, MG e cadastrados no programa Estratégia da Saúde da Família. Na primeira etapa, aplicou-se o questionário escrito padrão do através de questionários do ISSAC (International Study of Asthma and Allergies in Childhood) para coleta de dados pessoais, renda e prevalência de asma, rinite alérgica e eczema (N = 1131). Na segunda etapa (estudo do tipo caso-controle) dividiu-se a amostra em asmáticos (A; N = 172) e não asmáticos (NA; N = 379) para avaliar potenciais fatores associados à ocorrência de asma na população utilizando-se o questionário complementar do ISAAC fase II. Realizou-se também teste cutâneo de hipersensibilidade imediata (TCHI) e parasitológico. As razões de probabilidade (RP) estimadas por análise multivariada mostraram que os casos de asma estavam relacionados à frequência no jardim de infância, tabagismo intradomiciliar, antecedente familiar, rinite e resposta positiva ao TCHI. Conclui-se que na população estudada a prevalência da asma não está apenas relacionada à predisposição genética, mas também é associada ao histórico do indivíduo, sua condição social, exposição a poluentes como fumaça de tabaco e resposta positiva a alérgenos